Detail akcie aap Implantate Br online

Business Summary: aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . It also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The Company operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
Financial Summary: BRIEF: For the six months ended 30 June 2025, aap Implantate AG revenues decreased 3% to EUR6.2M. Net loss increased 11% to EUR983K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Sonstige betriebliche Erträge decrease of 36% to EUR609K (income), Sonstige betriebliche Aufwendungen increase of 3% to EUR3.2M (expense).